| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ESSA Pharma Inc. | Director | Options | 50,000 | 25 Mar 2024 | Direct | ||
| Carisma Therapeutics Inc. | Director | Stock Option (Right to Buy) | 19,350 | 26 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CARM | Carisma Therapeutics Inc. | 26 Jun 2024 | 1 | $0 | 4 | Director | 27 Jun 2024, 16:56 |
| EPIX | ESSA Pharma Inc. | 25 Mar 2024 | 1 | $0 | 4 | Director | 28 Mar 2024, 12:41 |
| CARM | Carisma Therapeutics Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 18:19 |
| CARM | Carisma Therapeutics Inc. | 07 Mar 2023 | 2 | $0 | 4 | Director | 09 Mar 2023, 20:23 |
| CARM | Carisma Therapeutics Inc. | 07 Mar 2023 | 0 | $0 | 3 | Director | 09 Mar 2023, 20:09 |
| EPIX | ESSA Pharma Inc. | 29 Jun 2022 | 1 | $0 | 4 | Director | 01 Nov 2022, 11:10 |